Spots Global Cancer Trial Database for tumor infiltrating lymphocytes (til)
Every month we try and update this database with for tumor infiltrating lymphocytes (til) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study Using Tumor-Reactive Autologous Tumor Infiltrating Lymphocytes (TIL) in Metastatic Melanomas | NCT02375984 | Metastatic Mela... | Tumor Infiltrat... | 18 Years - | Saint John's Cancer Institute | |
| E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers | NCT05686226 | Cervical Cancer Throat Cancer Oropharynx Canc... Anal Cancer Vulva Cancer Vaginal Cancer Penile Cancer Metastatic Canc... HPV-Related Mal... HPV-Related Car... HPV-Related Cer... HPV-Related Squ... HPV-Related Ade... HPV Positive Or... HPV-Associated ... HPV-Related Ade... HPV-Related End... HPV-Related Ana... HPV-Related Pen... HPV-Related Vul... HPV Positive Re... | E7 TCR-T cells | 18 Years - | Rutgers, The State University of New Jersey | |
| Study on TIL for the Treatment of r/r Gynecologic Tumors | NCT04766320 | Gynecologic Can... | Tumor Infiltrat... | 18 Years - 75 Years | Shanghai 10th People's Hospital | |
| Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers | NCT03935893 | Gastric Cancer Colorectal Canc... Pancreatic Canc... Sarcoma Mesothelioma Neuroendocrine ... Squamous Cell C... Merkel Cell Car... Mismatch Repair... Microsatellite ... | Tumor Infiltrat... Fludarabine + C... | 18 Years - 75 Years | University of Pittsburgh | |
| Adoptive T Cell Therapy in Patients With Recurrent Ovarian Cancer | NCT04072263 | Ovarian Cancer ... | Tumor Infiltrat... Interferon Alfa... Carboplatin Paclitaxel | 18 Years - | Leiden University Medical Center | |
| Study on TIL for the Treatment of r/r Gastrointestinal Tumors | NCT04960072 | Gastrointestina... | Tumor Infiltrat... | 18 Years - 75 Years | Shanghai Juncell Therapeutics | |
| Laboratory-Treated Autologous Lymphocytes and Aldesleukin After Cyclophosphamide and Fludarabine in Treating Patients With Metastatic Melanoma | NCT00863330 | Melanoma (Skin) | Tumor Infiltrat... | 18 Years - | Aurora Health Care | |
| Laboratory-Treated Autologous Lymphocytes and Aldesleukin After Cyclophosphamide and Fludarabine in Treating Patients With Metastatic Melanoma | NCT00863330 | Melanoma (Skin) | Tumor Infiltrat... | 18 Years - | Aurora Health Care | |
| Study on TIL for the Treatment of r/r Gynecologic Tumors | NCT04766320 | Gynecologic Can... | Tumor Infiltrat... | 18 Years - 75 Years | Shanghai 10th People's Hospital | |
| Study on TIL for the Treatment of Advanced Solid Tumors | NCT04967833 | Advanced Solid ... | Tumor Infiltrat... | 18 Years - 75 Years | Shanghai Juncell Therapeutics | |
| Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies | NCT04114136 | Melanoma NSCLC Hepatocellular ... Urothelial Canc... Gastric Adenoca... HNSCC Esophageal Aden... Microsatellite ... | Nivolumab or Pe... Metformin Rosiglitazone | 18 Years - | University of Pittsburgh | |
| Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies | NCT04114136 | Melanoma NSCLC Hepatocellular ... Urothelial Canc... Gastric Adenoca... HNSCC Esophageal Aden... Microsatellite ... | Nivolumab or Pe... Metformin Rosiglitazone | 18 Years - | University of Pittsburgh | |
| Study on TIL for the Treatment of Advanced Solid Tumors | NCT04967833 | Advanced Solid ... | Tumor Infiltrat... | 18 Years - 75 Years | Shanghai Juncell Therapeutics | |
| Study on TIL for the Treatment of r/r Gastrointestinal Tumors | NCT04960072 | Gastrointestina... | Tumor Infiltrat... | 18 Years - 75 Years | Shanghai Juncell Therapeutics | |
| Study on TIL for the Treatment of r/r Gastrointestinal Tumors | NCT04960072 | Gastrointestina... | Tumor Infiltrat... | 18 Years - 75 Years | Shanghai Juncell Therapeutics | |
| Study on TIL for the Treatment of Advanced Breast Cancer | NCT05142475 | Breast Cancer Treatment Side ... Advanced Breast... Effects of Immu... | Tumor Infiltrat... | 18 Years - 75 Years | Shanghai Juncell Therapeutics | |
| A Phase 2, Single-Center, Open Label Study of Autologous, Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Urothelial Carcinoma Patients | NCT04383067 | Metastatic Urot... | Tumor Infiltrat... Proleukin | 18 Years - | Sheba Medical Center | |
| A Phase 2, Single-Center, Open Label Study of Autologous, Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Urothelial Carcinoma Patients | NCT04383067 | Metastatic Urot... | Tumor Infiltrat... Proleukin | 18 Years - | Sheba Medical Center | |
| The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme. | NCT05333588 | Glioblastoma Mu... | Tumor Infiltrat... | 18 Years - 80 Years | Hebei Senlang Biotechnology Inc., Ltd. | |
| Study on TIL for the Treatment of Brain Glioma | NCT04943913 | Glioma | Tumor Infiltrat... | 18 Years - 75 Years | Shanghai Juncell Therapeutics | |
| Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers | NCT03801083 | Biliary Tract C... Cholangiocarcin... Biliary Tract N... | Tumor Infiltrat... | 18 Years - 75 Years | University of Pittsburgh | |
| A Phase 2, Single-Center, Open Label Study of Autologous, Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Urothelial Carcinoma Patients | NCT04383067 | Metastatic Urot... | Tumor Infiltrat... Proleukin | 18 Years - | Sheba Medical Center | |
| Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers | NCT03801083 | Biliary Tract C... Cholangiocarcin... Biliary Tract N... | Tumor Infiltrat... | 18 Years - 75 Years | University of Pittsburgh | |
| Ipilimumab With Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Melanoma Mets Pts | NCT01701674 | Metastatic Mela... | Ipilimumab Tumor Infiltrat... Administration ... Cyclophosphamid... Fludarabine as ... High Dose IL-2 Adoptive Cell T... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
